Abstract:Introduction: Familial hypertrophic cardiomyopathy (HCM), affecting 1 in 500 adults, is characterized by idiopathic thickening of the heart and impaired systolic function. Mechanisms through which cardiac sarcomeric mutations manifest in HCM are poorly understood. Hypothesis: We previously identified a novel MYH7 E848G mutation associated with HCM that manifested as left ventricular hypertrophy, diffuse fibrosis, and severe systolic dysfunction. We hypothesize that the E848G variant impairs tissue contractility and causes cell death in a dose-dependent manner. Methods: We created MYH7-EGFP expressing cardiomyocytes (CMs) with MYH7 wt/wt-EGFP , MYH7 wt/E848G-EGFP , or MYH7 E848G/E848G-EGFP alleles using patient-derived induced pluripotent stem cells (hiPSCs), CRISPR-Cas9 gene-editing, and standard differentiation protocols. CMs were cocultured with stromal cells to create 3D engineered heart tissues (EHTs) or cultured as a monolayer in high calcium stress media. EHTs were enzymatically digested and GFP+ cardios were sorted for analysis. Results: Monolayer MYH7 wt/E848G-EGFP CMs had higher TUNEL + percentage (13.1 ± 2.1%) at d33 and lower cell survival (52.0 ± 6.6% of d30 seeded) at d42 relative to MYH7 wt/wt-EGFP (6.6 ± 2.6%; 107 ± 2.1%). Screening revealed elevated levels of proteins associated with intrinsic apoptosis (p53, 1.93 ± .03-fold; p21, 1.66 ± .10-fold; Bax, 1.56 ± .11-fold) in MYH7 wt/E848G-EGFP CMs at d35 relative to MYH7 wt/wt-EGFP . MYH7 wt/E848G-EGFP (n = 20; 67.5 ± 9.0 μN) had reduced maximum active twitch force relative to MYH7 wt/wt-EGFP (n = 19; 226 ± 17 μN) 14 days post-cast. MYH7 wt/E848G-EGFP EHTs had lower percentage of EGFP + cells (13.5 ± 0.8%) 7 days post-cast relative to MYH7 wt/wt-EGFP (25.8 ± 0.8%). EGFP + cells sorted from 7 day post-cast MYH7 wt/E848G-EGFP EHTs had elevated TP53 transcription (1.67 ± .29-fold) relative to MYH7 wt/wt-EGFP . Conclusion: These results suggest MYH7 E848G mutation reduces sarcomere contractility and induces p53-associated cell death. High calcium stress media induces cell death that likely contributes to contractile dysfunction seen in MYH7 E848G HCM. Ongoing studies will elucidate mechanisms through which E848G activates intrinsic apoptosis.

Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium-activated tension and stiffness and reduces myofilament Ca<SUP>2+</SUP> sensitivity

Hypertrophic cardiomyopathy associated E22K mutation in myosin regulatory light chain decreases calcium‐activated tension and stiffness and reduces myofilament Ca <sup>2+</sup> sensitivity

Enhanced Basal Activity of a Cardiac Ca2+ Release Channel (ryanodine Receptor) Mutant Associated with Ventricular Tachycardia and Sudden Death.

Hypercontractile mutant of ventricular myosin essential light chain leads to disruption of sarcomeric structure and function and results in restrictive cardiomyopathy in mice

Myosin Rod Hypophosphorylation and CB Kinetics in Papillary Muscles from a TnC-A8V KI Mouse Model.

Inhibition of HSC70 Alleviates Hypertrophic Cardiomyopathy Pathology in Human Induced Pluripotent Stem Cell‐derived Cardiomyocytes with a MYBPC3 Mutation

Molecular mechanisms of cardiomyopathy phenotypes associated with myosin light chain mutations

Cardiac Contractility, Motor Function, and Cross‐bridge Kinetics in N47K‐RLC Mutant Mice

Structural and Functional Aspects of the Myosin Essential Light Chain in Cardiac Muscle Contraction

Hypertrophic cardiomyopathy mutations Y115H and E497D disrupt the folded-back state of human β-cardiac myosin allosterically

Diversity and Similarity of Motor Function and Cross-Bridge Kinetics in Papillary Muscles of Transgenic Mice Carrying Myosin Regulatory Light Chain Mutations D166V and R58Q.

Cross-Bridge Kinetics In Papillary Muscle Fibers From Transgenic Mice Expressing The Aspargine-47 To Lysine (N47k) Mutation In Myosin Regulatory Light Chain

Age-Related Cardiac Dysfunction In Transgenic Mice Carrying Actin E99k Mutation

Remodeling of the heart in hypertrophy in animal models with myosin essential light chain mutations

Development of apical hypertrophic cardiomyopathy with age in a transgenic mouse model carrying the cardiac actin E99K mutation

An In Silico Cardiomyocyte Reveals the Impact of Changes in CaMKII Signalling on Cardiomyocyte Contraction Kinetics in Hypertrophic Cardiomyopathy

Constitutive phosphorylation of cardiac myosin regulatory light chain prevents development of hypertrophic cardiomyopathy in mice

Abstract P2110: Myosin-7 E848G Mutation Reduces Contractility And Activates P53-associated Intrinsic Apoptosis In Patient-derived Induced Pluripotent Stem Cell Model Of Hypertrophic Cardiomyopathy

An Cardiomyocyte Reveals the Impact of Changes in CAMKII Signalling on Cardiomyocyte Contraction Kinetics in Hypertrophic Cardiomyopathy

Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways.

Dilated cardiomyopathy mutation in beta-cardiac myosin enhances actin activation of the power stroke and phosphate release